Koyfin Home > Directory > Health Care > Adamas Pharma > Cash Flow from Operations

Adamas Pharma Cash Flow from Operations Chart (ADMS)

Adamas Pharma annual/quarterly Cash Flow from Operations from 2012 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Adamas Pharma Cash Flow from Operations for the quarter ending June 06, 2020 was $-12m a -52.75% increase of 6m year over year
  • Adamas Pharma Cash Flow from Operations for the last 12 months ending June 06, 2020 was $-67m a -29.43% increase of 20m year over year
  • Adamas Pharma Annual Cash Flow from Operations for 2019 was $-81m a -29.02% increase of 23m from 2018
  • Adamas Pharma Annual Cash Flow from Operations for 2018 was $-104m a 35.88% decrease of -37m from 2017
  • Adamas Pharma Annual Cash Flow from Operations for 2017 was $-67m a 28.07% decrease of -19m from 2016
Other Cash Flow Metrics:
  • Adamas Pharma Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-33m a 50.48% decrease of -17m year over year
  • Adamas Pharma Total Revenue for the quarter ending September 09, 2018 was $11m a 94.65% increase of 10m year over year
View Chart On Koyfin

Quarterly ADMS Cash Flow from Operations Data

06/2020$-12m
03/2020$-17m
12/2019$-18m
09/2019$-19m
06/2019$-23m
03/2019$-21m
12/2018$-24m
09/2018$-23m
06/2018$-33m
03/2018$-25m

Annual ADMS Cash Flow from Operations Data

2019$-81m
2018$-104m
2017$-67m
2016$-48m
2015$-47m
2014$28m
2013$27m
2012$52m
2011$-7m